'First of its kind' drug that delays type 1 diabetes by up to three years is approved by the NHS ⊕⊕
found
a story from The Daily Mail 💩 › The Daily Mail
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
The National Institute for Health and Care Excellence (Nice) has approved teplizumab, with Diabetes UK saying it 'marks the start of a new age of treatment'.